The present invention relates to recombinant human BACE polypeptides. More particularly, the invention relates to recombinant human BACE polypeptides that have a modified amino acid sequence at position 33 of the BACE sequence, as well as to polynucleotides, expression vectors, host cells, and methods for producing the modified recombinant human BACE polypeptides.


< Mortierella alpina glycerol-3-phosphate o-acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms

< Mk2 interacting proteins

> Use of spliceosome mediated RNA trans-splicing for immunotherapy

> Avermectins and avermectin monosaccharides substituted in the 4'-and 4"-position having pesticidal properties

~ 00258